实用老年医学 ›› 2023, Vol. 37 ›› Issue (9): 869-872.doi: 10.3969/j.issn.1003-9198.2023.09.002
王琳琳, 杨诗怡, 徐俊
收稿日期:2023-03-23
出版日期:2023-09-20
发布日期:2023-09-20
通讯作者:
徐俊,Email:neurojun@126.com
作者简介:徐俊 教授
基金资助:
Received:2023-03-23
Online:2023-09-20
Published:2023-09-20
中图分类号:
王琳琳, 杨诗怡, 徐俊. 人工智能在阿尔茨海默病中的研究进展[J]. 实用老年医学, 2023, 37(9): 869-872.
| [1] CHANG C H, LIN C H, LANE H Y. Machine learning and novel biomarkers for the diagnosis of Alzheimer's disease[J].Int J Mol Sci, 2021, 22(5):2761. [2] JAMES C, RANSON J M, EVERSON R, et al. Performance of machine learning algorithms for predicting progression to dementia in memory clinic patients[J]. JAMA Netw Open, 2021,4(12):e2136553. [3] KLEIMAN M J, BARENHOLTZ E, GALVIN J E, et al. Alzheimer's disease neuroimaging initiative. Screening for early-stage alzheimer's disease using optimized feature sets and machine learning[J]. J Alzheimers Dis, 2021,81(1):355-366. [4] WANG X, JIAO B, LIU H, et al. Machine learning based on optical coherence tomography images as a diagnostic tool for Alzheimer's disease[J]. CNS Neurosci Ther,2022,28(12):2206-2217. [5] GALVIN J E, KLEIMAN M J, WALKER M. Using optical coherence tomography to screen for cognitive impairment and dementia[J]. J Alzheimers Dis, 2021,84(2):723-736. [6] COSTANZO E, LENGYEL I, PARRAVANO M, et al. Ocular biomarkers for Alzheimer disease dementia: an umbrella review of systematic reviews and meta-analyses[J]. JAMA Ophthalmol, 2023,141(1):84-91. [7] CHEUNG C Y, RAN A R, WANG S, et al. A deep learning model for detection of Alzheimer's disease based on retinal photographs: a retrospective, multicentre case-control study[J]. Lancet Digit Health, 2022, 4(11):e806-e815. [8] HUA R, XIONG J, LI G, et al. Development and validation of a deep learning algorithm based on fundus photographs for estimating the CAIDE dementia risk score[J]. Age Ageing, 2022, 51(12):afac282. [9] CRAWFORD T J, HIGHAM S, RENVOIZE T, et al. Inhibitory control of saccadic eye movements and cognitive impairment in Alzheimer's disease[J]. Biol Psychiatry,2005,57(9):1052-1060. [10] WILCOCKSON T D W, MARDANBEGI D, XIA B, et al. Abnormalities of saccadic eye movements in dementia due to Alzheimer's disease and mild cognitive impairment[J]. Aging:Albany NY,2019,11(15):5389-5398. [11] RIZZO A, ERMINI S, ZANCA D,et al. A machine learning approach for detecting cognitive interference based on eye-tracking data[J]. Front Hum Neurosci, 2022, 16:806330. [12] AHMED S, HAIGH A M, DE JAGER C A, et al. Connected speech as a marker of disease progression in autopsy-proven Alzheimer's disease[J]. Brain,2013,136(Pt 12):3727-3737. [13] WANG T, HONG Y, WANG Q, et al. Identification of mild cognitive impairment among chinese based on multiple spoken tasks[J]. J Alzheimers Dis, 2021, 82(1):185-204. [14] EYIGOZ E, MATHUR S, SANTAMARIA M,et al. Linguistic markers predict onset of Alzheimer's disease[J]. EClinicalMedicine, 2020, 28:100583. [15] AGBAVOR F, LIANG H. Predicting dementia from spontaneous speech using large language models[J]. PLOS Digit Health, 2022,1(12):e0000168. [16] BATEMAN R J, XIONG C, BENZINGER T L, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease[J]. N Engl J Med,2012,367(9):795-804. [17] EZZATI A, ABDULKADIR A, JACK C R Jr,et al. Predictive value of ATN biomarker profiles in estimating disease progression in Alzheimer's disease dementia[J]. Alzheimers Dement, 2021, 17(11):1855-1867. [18] SANZ-BLASCO R, RUIZ-SÁNCHEZ DE LEÓN J M, ÁVILA-VILLANUEVA M, et al. Transition from mild cognitive impairment to normal cognition: determining the predictors of reversion with multi-state Markov models[J].Alzheimers Dement,2022,18(6):1177-1185. [19] HAMMOND T C, XING X, WANG C, et al. β-amyloid and tau drive early Alzheimer's disease decline while glucose hypometabolism drives late decline[J]. Commun Biol, 2020,3(1):352. [20] HARPER L, BARKHOF F, FOX N C,et al. Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales[J]. J Neurol Neurosurg Psychiatry,2015,86(11):1225-1233. [21] KOIKKALAINEN J R, RHODIUS-MEESTER H F M, FREDERIKSEN K S, et al. Automatically computed rating scales from MRI for patients with cognitive disorders[J]. Eur Radiol, 2019, 29(9):4937-4947. [22] ODUSAMI M, MASKELIŪNAS R, DAMAŠEVIČIUS R, et al. Analysis of features of Alzheimer's disease: detection of early stage from functional brain changes in magnetic resonance images using a finetuned ResNet18 network[J]. Diagnostics:Basel, 2021, 11(6):1071.[23] PARK J H, CHO H E, KIM J H,et al. Machine learning prediction of incidence of Alzheimer's disease using large-scale administrative health data[J]. NPJ Digit Med, 2020, 3:46. [24] JONES D, LOWE V, GRAFF-RADFORD J, et al. A computational model of neurodegeneration in Alzheimer's disease[J]. Nat Commun, 2022, 13(1):1643. [25] BADER J M, GEYER P E, MÜLLER J B, et al. Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease[J]. Mol Syst Biol, 2020, 16(6):e9356. [26] GIORGIO J, JAGUST W J, BAKER S, et al. A robust and interpretable machine learning approach using multimodal biological data to predict future pathological tau accumulation[J]. Nat Commun, 2022, 13(1):1887. [27] ZHANG B, GAITERI C, BODEA LG, et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease[J]. Cell, 2013,153(3):707-720. [28] MICANOVIC C, PAL S. The diagnostic utility of EEG in early-onset dementia: a systematic review of the literature with narrative analysis[J]. J Neural Transm: Vienna, 2014,121(1):59-69. [29] IERACITANO C, MAMMONE N, HUSSAIN A, et al. A novel multi-modal machine learning based approach for automatic classification of EEG recordings in dementia[J]. Neural Netw,2020,123:176-190. [30] RODRIGUEZ S, HUG C, TODOROV P, et al. Machine learning identifies candidates for drug repurposing in Alzheimer's disease[J]. Nat Commun,2021,12(1):1033. [31] XIE C, ZHUANG X X, NIU Z, et al. Amelioration of Alzheimer's disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow[J]. Nat Biomed Eng, 2022, 6(1):76-93. [32] 冷敏敏,张萍,胡明月,等.宠物机器人在老年痴呆患者照护中的应用进展[J].中华护理杂志,2018,53(12):1498-1503. [33] ENSHAEIFAR S, ZOHA A, SKILLMAN S, et al. Machine learning methods for detecting urinary tract infection and analysing daily living activities in people with dementia[J]. PLoS One,2019,14(1):e0209909. |
| [1] | 孙丽, 尹卫红, 经俊, 钱夏丽. 亚麻醉剂量艾司氯胺酮对老年脊柱手术病人术后早期认知功能障碍的影响[J]. 实用老年医学, 2024, 38(10): 1039-1043. |
| [2] | 董丽华, 李加梅, 郑加平, 雷小晶. 血液生物标志物在阿尔茨海默病早期诊断中的研究进展[J]. 实用老年医学, 2023, 37(12): 1249-1254. |
| [3] | 王敏, 郭文军, 汤忠泉, 赵晓敏, 欧婷, 李云涛. 听力障碍与阿尔茨海默病相关性的Meta分析[J]. 实用老年医学, 2023, 37(9): 915-919. |
| [4] | 段景宜, 刘静, 查玉航, 杨巧露, 何海洋, 马亚男, 高海英. 阿尔茨海默病医防融合模式的探索[J]. 实用老年医学, 2023, 37(8): 757-760. |
| [5] | 张绍敏, 吴锦晖. COVID-19与阿尔茨海默病的最新研究进展[J]. 实用老年医学, 2023, 37(5): 521-523. |
| [6] | 赵璨, 冯美江. 外泌体与阿尔茨海默病的研究进展[J]. 实用老年医学, 2023, 37(4): 335-338. |
| [7] | 朱贺, 殷实. 认知障碍与抑郁症关系的研究进展[J]. 实用老年医学, 2023, 37(3): 234-237. |
| [8] | 郭晓娟, 刘洁, 王瑾, 陆文惠, 高玲, 屈秋民. 西安地区阿尔茨海默病病人药物依从性调查及影响因素分析[J]. 实用老年医学, 2023, 37(1): 47-50. |
| [9] | 张伟, 王蓉. 衰老作为神经退行性疾病危险因素的科学现状分析[J]. 实用老年医学, 2023, 37(10): 984-988. |
| [10] | 时建铨, 郑慧芬, 徐畅, 王变荣. 认知障碍简明评价量表与Addenbrooke认知评估量表Ⅲ诊断阿尔茨海默病的准确性比较[J]. 实用老年医学, 2023, 37(10): 1041-1043. |
| [11] | 阎子花, 杜静, 宋竹梅, 张兴梅, 张楠. 痴呆病人病感失认测评工具的研究进展[J]. 实用老年医学, 2023, 37(10): 1059-1063. |
| [12] | 叶念思, 胡慧, 邓蓓, 刘雪婷, 周诗, 李雨灿, 王晓梦. 轻度认知障碍老年人口腔健康相关生活质量现状及影响因素分析[J]. 实用老年医学, 2024, 38(7): 674-678. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
|
